LINC01504: A Drug Target / Disease Biomarker (G100507540)

Target Name: LINC01504

NCBI ID: G100507540

LINC01504

Other Name(s): Long intergenic non-protein coding RNA 1504, transcript variant 1 | long intergenic non-protein coding RNA 1504

LINC01504: A Drug Target / Disease Biomarker

LINC01504 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell's intercellular signaling, which is critical for various cellular processes such as cell growth, differentiation, and survival. LINC01504 is expressed in most tissues and cells, and its levels have been shown to be regulated by various factors, including growth factors, chemokines, and development factors.

The discovery and characterization of LINC01504 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases. LINC01504 has been shown to play a role in the regulation of various cellular processes, including cell adhesion, migration, and survival. It has also been shown to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and progression of many diseases, including cancer.

In addition to its role in cellular signaling, LINC01504 has also been shown to play a role in the regulation of gene expression. It has been shown to interact with various transcription factors, including NF-kappa-B, AP-1, and STAT3. These transcription factors are responsible for regulating the expression of genes that are involved in various cellular processes, including cell growth, differentiation, and survival. The regulation of gene expression by LINC01504 and its interacting transcription factors has important implications for the development of new treatments for diseases that are caused by disruptions in gene expression.

The potential utility of LINC01504 as a drug target and biomarker is significant. Its role in the regulation of cellular signaling pathways and gene expression makes it a potential target for small molecules that can modulate its activity. Additionally, its broad expression across various tissues and cells makes it a potential biomarker for a variety of diseases.

In conclusion, LINC01504 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its role in the regulation of cellular signaling pathways and gene expression makes it a potential target for small molecules that can modulate its activity. Further research is needed to determine its utility as a drug and to develop new treatments for diseases caused by disruptions in its function.

Protein Name: Long Intergenic Non-protein Coding RNA 1504

The "LINC01504 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01504 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets